Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link
Dow Jones Industrial Average
) is trading up 107 points (+0.7%) at 16,379 as of Friday, Feb 28, 2014, 1:34 p.m. ET. During this time, 188.8 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 400.9 million. The NYSE advances/declines ratio sits at 2,080 issues advancing vs. 879 declining with 152 unchanged.
- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
The Dow component leading the way higher looks to be
), which is sporting a $1.61 gain (+2.1%) bringing the stock to $77.63. This single gain is lifting the Dow Jones Industrial Average by 12.19 points or roughly accounting for 11.4% of the Dow's overall gain. Volume for UnitedHealth Group currently sits at 2.7 million shares traded vs. an average daily trading volume of 4.9 million shares.
UnitedHealth Group has a market cap of $75.24 billion and is part of the health care sector and health services industry. Shares are up 1% year to date as of Thursday's close. The stock's dividend yield sits at 1.5%.
UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States.
TheStreet Ratings rates UnitedHealth Group as a
. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, increase in net income, revenue growth and attractive valuation levels. We feel these strengths outweigh the fact that the company shows weak operating cash flow.
- You can view the full UnitedHealth Group Ratings Report.